At the news
? NEUTRALIMPACT 5/10 25-NSE filed Jul 27, 2026 at 08:57 ET
The New York Stock Exchange filed a Form 25-NSE to delist Avanos Medical, Inc. (AVNS) following the completion of its going-private merger with A-AV MergerSub, Inc., an affiliate of American Industrial Partners. The merger closed on July 27, 2026, with each share of AVNS common stock converted into $25.00 in cash. Trading was suspended immediately, and delisting will be effective August 7, 2026.
- Merger closed July 27, 2026; each share of AVNS common stock converted into $25.00 cash.
- Trading suspended on NYSE as of July 27, 2026; delisting effective August 7, 2026.
- Acquirer is A-AV MergerSub, Inc., a wholly-owned subsidiary of A-AV Holdco I, Inc., affiliated with investment funds advised by American Industrial Partners.
- The filing is a procedural notification under Rule 12d2-2(a)(3) for securities that now represent only the right to receive cash.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access